DUBLIN--(BUSINESS WIRE)--Covidien Ltd. (NYSE: COV; BSX: COV) today announced the results from its Annual General Meeting. Three proposals were on the meeting agenda:

• Election of Directors
• Approval of the amended and restated Covidien Ltd. 2007 Stock and Incentive Plan, and
• Appointment of Independent Auditors.

At the meeting, shareholders elected all 11 nominees, each of whom currently serves on Covidien’s Board of Directors. They are: Craig Arnold, Robert H. Brust, John M. Connors, Jr., Christopher J. Coughlin, Timothy M. Donahue, Kathy J. Herbert, Randall J. Hogan, III, Richard J. Meelia, Dennis H. Reilley, Tadataka Yamada, and Joseph A. Zaccagnino.

Shareholders also approved the amended and restated Covidien Ltd. 2007 Stock and Incentive Plan, as well as the appointment of Deloitte & Touche LLP to serve as the Company’s independent auditors.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2008 revenue of nearly $10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.

Contacts